Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reason
Reason
Jeffrey A. Singer

EXPLAINED: Cancer vaccines are advancing can regulators keep up | Rare Historical Photos

Within the past week, researchers announced the results of two major clinical trials that could herald a new era in cancer treatment. Scientists are learning how to teach the immune system to fight cancer and, potentially, prevent certain cancers from developing in the first place. Their discoveries also challenge the way the Food and Drug Administration (FDA) evaluates new medicines.

On November 17, Memorial Sloan Kettering Cancer Center announced that an experimental vaccine significantly prolonged survival in patients with acute myeloid leukemia (AML), a deadly cancer of the blood and bone marrow. Six days earlier, The New England Journal of Medicinepublished the results of a clinical trial demonstrating that a personalized messenger RNA (mRNA) vaccine reduced the likelihood that melanoma, a potentially deadly form of skin cancer, would recur after surgery.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.